1 follower
ERS Genomics was formed to commercialize the foundational CRISPR-Cas9 intellectual property held by co-inventor, co-owner, and Nobel Prize-winner Dr. Emmanuelle Charpentier. Licenses are available in multiple fields of use.
Immunome
2 followers
Amgen
201 followers
Elicio Therapeutics
1 follower
Miami Foundation
2 followers
Cytokinetics
11 followers
Capricor Therapeutics
1 follower
4D Molecular Therapeutics
3 followers
The Cumulus Coffee Company
2 followers
BridgeBio
2 followers
Artiva Biotherapeutics
1 follower
Thermo Fisher Scientific
160 followers
Explore companies